The E670G SNP in the PCSK9 gene is associated with polygenic hypercholesterolemia in men but not in women

BMC Medical Genetics

Volumn 7, Issue , 2006, Pages

  Evans, David ^a   Beil, Frank U ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; GLUTAMIC ACID; GLYCINE; HIGH DENSITY LIPOPROTEIN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; PROTEIN PCSK 9; PROTEINASE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; DISEASE ASSOCIATION; EUROPE; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GERMANY; HAPLOTYPE; HUMAN; HYPERCHOLESTEROLEMIA; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MUTATION RATE; POLYGENIC HYPERCHOLESTEROLEMIA; POPULATION RESEARCH; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; UNIVERSITY HOSPITAL;

ADULT; ALLELES; CHOLESTEROL, LDL; FEMALE; GENE FREQUENCY; HUMANS; HYPERCHOLESTEROLEMIA; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROPROTEIN CONVERTASES; SERINE ENDOPEPTIDASES; SEX FACTORS;

EID: 33748601835     PISSN: 14712350     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/1471-2350-7-66     Document Type: Article

References (6)

1. Third report of the National Cholesterol EducationProgramme (NCEP) Expert Panel on Detection, Evaluation, and treatment of High Blood Cholesterol in Adult (Adult Treatment Panel III): final report. Circulation 2002, 106:3143-421.
2. Rader DJ, Cohen J, Hobbs HH: Monogenichypercholesterolemia: new insights in pathogenesis and treatment. J Clin Invest 2003, 111:1795-1803.
3. Abifadel M, Varret M, Rabes JP, Allard D, Ouguerram K, Devilliars M, Cruard C, Benjannet S, Wickham L, Erlich D, Derre A, Villeger L, Farnier M, Beucler I, Bruckert E, Chambaz J, Chanau B, Lecerf J, Luc G, Moulin P, Wiessenbach J, Prat A, Krempf M, Junien C, Seidah NG, Boileau C: Mutations in PCSK9 cause autosomal dominanthypercholesterolemia. Nat Genet 2003, 34:154-156.
4. Kotowski IK, Pertsemlidis A, Luke A, Cooper RS, Vega GL, Cohen JC, Hobbs HH: A spectrum of PCSK9 alleles contributes to plasma levels of low density lipoprotein cholesterol. Am J Hum Genet 2006, 78:410-22.
5. Chen SN, Ballantyne CM, Gotto AM, Tan Y, Willerson JT, Marian AJ: A common PCSK9 haplotype, encompassing the E670G coding single nucleotide polymorphism, is a novel genetic marker for plasma low-density lipoprotein cholesterol levels and the severity of coronary atherosclerosis. J Am Coll Cardiol 2005, 45:1611-1619.
6. Shioji K, Mannami T, Kokubo Y, Inamoto N, Takagi S, Goto, Y, Nonogi H, Iwai N: Genetic variants in PCSK9 affect the cholesterol level in Japenese. J Hum Genet 2004, 49:109-114.